In this episode of Trends in Modern Bio Separation Workflows brought to you by Advanced Materials Technology, Joseph Glajch Ph.D., President and Chief Consultant, JLP AP Consulting LLC,discusses how the landscape of bio separations has evolved, how monoclonal antibodies have dominated the market, the current challenges for research scientists and the tools available to them and lastly where he sees the future of LC bio separations.
Nano-liquid chromatography-high-resolution tandem mass spectrometry (nano-LC-HRMS/MS) reveals saliva protein shifts before and after multiple sclerosis therapy.
Max Besenhard explains how hybrid mechanistic and machine learning models can make HPLC method development quicker, more robust and ready for autonomous digital twins.